Sophie Joukoff Selected Research

Renal Tubular Acidosis (Distal Renal Tubular Acidosis)

7/2023	Bone mineral density and growth changes in patients with distal renal tubular acidosis after two-years treatment with a new alkalizing drug (ADV7103).
11/2022	Improved growth of a child with primary distal renal tubular acidosis after switching from a conventional alkalizing treatment to a new prolonged-release formulation containing potassium citrate and potassium bicarbonate: lessons for the clinical nephrologist.
1/2022	Lived experiences of patients with distal renal tubular acidosis treated with ADV7103 and of their caregivers: a qualitative study.
1/2021	Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sophie Joukoff Research Topics

Disease

4	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 07/2023 - 01/2021
1	Acidosis 07/2023
1	Hearing Loss (Hearing Impairment) 01/2022
1	Rare Diseases (Rare Disease) 01/2022

Drug/Important Bio-Agent (IBA)

4	potassium bicarbonateIBA 07/2023 - 01/2021
4	Potassium Citrate FDA LinkGeneric 07/2023 - 01/2021
3	dirhodium tetraacetate (DRTA)IBA 07/2023 - 01/2021